These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37659714)

  • 1. The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis.
    You Z; Wang C; Lan X; Li W; Shang D; Zhang F; Ye Y; Liu H; Zhou Y; Ning Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110849. PubMed ID: 37659714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic features of adolescent major depressive disorder: A comparative study between treatment-resistant depression and first-episode drug-naive depression.
    Gan X; Li X; Cai Y; Yin B; Pan Q; Teng T; He Y; Tang H; Wang T; Li J; Zhu Z; Zhou X; Li J
    Psychoneuroendocrinology; 2024 Sep; 167():107086. PubMed ID: 38824765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposing.
    Fabbri C; Pain O; Hagenaars SP; Lewis CM; Serretti A
    Neuropsychopharmacology; 2021 Sep; 46(10):1821-1829. PubMed ID: 34158615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of amplitude of low-frequency fluctuation in treatment-resistant versus non-treatment-resistant depression patients.
    Zhang A; Li G; Yang C; Liu P; Wang Y; Kang L; Wang Y; Zhang K
    Neuropsychiatr Dis Treat; 2019; 15():2119-2128. PubMed ID: 31413577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.
    Rathod S; Denee T; Eva J; Kerr C; Jacobsen N; Desai M; Baldock L; Young AH
    J Affect Disord; 2022 Mar; 300():551-562. PubMed ID: 34965398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression.
    Kosanovic Rajacic B; Sagud M; Begic D; Nikolac Perkovic M; Dvojkovic A; Ganoci L; Pivac N
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
    Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
    BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations.
    Gbaoui L; Fachet M; Lüno M; Meyer-Lotz G; Frodl T; Hoeschen C
    Front Psychiatry; 2022; 13():1061326. PubMed ID: 36590606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study.
    Pappa S; Shah M; Young S; Anwar T; Ming T
    BJPsych Open; 2024 Jan; 10(1):e32. PubMed ID: 38240079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study.
    Denee T; Kerr C; Ming T; Wood R; Tritton T; Middleton-Dalby C; Massey O; Desai M
    J Psychiatr Res; 2021 Jul; 139():172-178. PubMed ID: 34077893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder.
    Shah D; Zheng W; Allen L; Wei W; LeMasters T; Madhavan S; Sambamoorthi U
    Curr Med Res Opin; 2021 May; 37(5):847-859. PubMed ID: 33686881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder.
    Wu Z; Yu H; Tian Y; Wang Y; He Y; Lan T; Li Y; Bai M; Chen X; Chen Z; Ji P; Zhang H; Jin X; Song J; Cheng K; Xie P
    Front Psychiatry; 2021; 12():810302. PubMed ID: 35264984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents.
    Zhou X; Liu L; Lan X; Cohen D; Zhang Y; Ravindran AV; Yuan S; Zheng P; Coghill D; Yang L; Hetrick SE; Jiang X; Benoliel JJ; Cipriani A; Xie P
    Mol Psychiatry; 2019 Oct; 24(10):1478-1488. PubMed ID: 29679072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Evaluation of the Clinical and Economic Burden Among Older Adult Medicare-Covered Beneficiaries With Treatment-Resistant Depression.
    Benson C; Szukis H; Sheehan JJ; Alphs L; Yuce H
    Am J Geriatr Psychiatry; 2020 Mar; 28(3):350-362. PubMed ID: 31735488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Descriptive analysis of the economic burden of treatment resistance in a major depressive episode.
    Cai Q; Sheehan JJ; Wu B; Alphs L; Connolly N; Benson C
    Curr Med Res Opin; 2020 Feb; 36(2):329-335. PubMed ID: 31540559
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression.
    Lauden A; Geishin A; Merzon E; Korobeinikov A; Green I; Golan-Cohen A; Vinker S; Manor I; Weizman A; Magen E
    Brain Behav Immun Health; 2021 Oct; 16():100313. PubMed ID: 34589804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts.
    Fabbri C; Hagenaars SP; John C; Williams AT; Shrine N; Moles L; Hanscombe KB; Serretti A; Shepherd DJ; Free RC; Wain LV; Tobin MD; Lewis CM
    Mol Psychiatry; 2021 Jul; 26(7):3363-3373. PubMed ID: 33753889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.